Tejara Capital LTD Roivant Sciences Ltd. Call Options Transaction History
Tejara Capital LTD
- $275 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
308Shares Held
497MCall Options Held
989KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$812 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$787 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$759 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$403 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$334 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.02B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...